Course overview
Recent advances in medical and microbial molecular biotechnology, have led to great strides in the understanding and treatment of human diseases. Recognising the impact of these advances on human health and economic development, scientists and industry are harnessing these enabling technologies to meet the new challenges in medical microbiology and infectious diseases. This course develops key concepts in molecular bacteriology and virology, identifying key targets for rational vaccine design, use of animal models to determine immune responses to vaccines and assessment of efficacy, development of new generation vaccines, and regulation of vaccine production and quality control.